Patents by Inventor Xiaojuan Zhang

Xiaojuan Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11963049
    Abstract: An information processing method provided in the present disclosure includes: allocating, to a Non-Terrestrial Network (NTN) cell, at least one of a frequency band dedicated to the NTN cell, a frequency dedicated to the NTN cell, and a Physical Cell Identifier (PCI) dedicated to the NTN cell; notifying User Equipment (UE) of at least one of the following information: a frequency band indicator of the frequency band, the frequency, and the PCI.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: April 16, 2024
    Assignee: ZTE CORPORATION
    Inventors: Xiaojuan Shi, He Huang, Nan Zhang, Jianwu Dou
  • Publication number: 20230348471
    Abstract: A type of Bruton's tyrosine kinase inhibitor, a preparation method therefor, and an application thereof in the field of medicine. The Bruton's tyrosine kinase inhibitor may be used for preventing and/or treating a disease related to Bruton's tyrosine kinase mediation, such as an autoimmune disease, cancer, or an inflammatory disease. Through experimental research, the provided compound has high selectivity with respect to a Bruton's tyrosine kinase target, and can exhibit a uniquely advantageous medicinal effect in an in vivo animal experiment.
    Type: Application
    Filed: June 18, 2021
    Publication date: November 2, 2023
    Inventors: Xin Xu, Jia Chen, Guan Wang, Linli Zhang, Qingyun Jiang, Chenghao Xi, Kang Sun, Xiaojuan Zhang, Chunqiao Chen, Shuai Li, Qiang Li, Liangze Xia, Ying Wang, Xiaoer Xia
  • Publication number: 20230111910
    Abstract: Provided are a compound as a PD-L1 inhibitor, a preparation method therefor, and use thereof. Further provided is use of the compound or a pharmaceutical composition thereof in the preparation of a medicine, wherein the medicine is used for preventing and treating a PD-L1-related disease.
    Type: Application
    Filed: January 21, 2021
    Publication date: April 13, 2023
    Inventors: Xin XU, Jia CHEN, Liming ZHANG, Xuqin YANG, Maozhi YANG, Xiaojuan ZHANG, Yanxiao XU, Xiaobo ZHOU, Hao YU, Yuyun ZHANG, Ying WANG, Xiaoer XIA
  • Publication number: 20220380796
    Abstract: The present invention provides methods and compositions for identifying, selecting, and/or producing a soybean plant or germplasm resistant to Asian soybean rust using markers, genes and chromosomal intervals derived from Glycine max strain SX6907. Asian soybean rust resistant soybean seeds, plants, and germplasms are also provided.
    Type: Application
    Filed: July 1, 2020
    Publication date: December 1, 2022
    Applicants: OIL CROPS RESEARCH INSTITUTE, CHINESE ACADEMY..., SYNGENTA CROP PROTECTION AG, SYNGENTA BIOTECHNOLOGY CHINA CO, LTD
    Inventors: Zhihui SHAN, Qingnan HAO, Haifeng CHEN, Yanyan YANG, Chanjuan ZHANG, Limiao CHEN, Songli YUAN, Dong CAO, Wei GUO, Xiaojuan ZHANG, Shuilian CHEN, Zhonglu YANG, Dezhen QIU, Xinan ZHOU, Qingli LIU, Becky Welsh BREITINGER, Shujie DONG
  • Publication number: 20220185816
    Abstract: Related are a JAK kinase inhibitor, a preparation method for same, and applications thereof in the field of medicine, related to the field of medicinal chemistry. Provided is a novel small molecule JAK inhibitor, which has the structure as represented by formula (II). The compound provides improved efficacy and safeness in preventing or treating a JAK-related indication.
    Type: Application
    Filed: March 11, 2020
    Publication date: June 16, 2022
    Applicants: SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD, ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
    Inventors: Xin XU, Jia CHEN, Zhen ZHANG, Guan WANG, Linli ZHANG, Qiang LI, Chenghao XI, Minkai QU, Xiaojuan ZHANG, Chunqiao CHEN, Fan YANG, Xiaoer XIA, Yijin WANG, Yunfei LI, Jian GE
  • Publication number: 20220098178
    Abstract: The present invention relates to a preparation method for an amide compound and an application thereof in the field of medicine. Specifically, provided by the present invention is an amide small molecule compound which is an inhibitor of Zeste gene enhancer homolog 2 (EZH2) and which may be used to prevent and/or treat EZH2-mediated related diseases, comprising tumors, myeloproliferative diseases or autoimmune diseases.
    Type: Application
    Filed: March 24, 2020
    Publication date: March 31, 2022
    Inventors: Xin XU, Jia CHEN, Zhen ZHANG, Liming ZHANG, Qimei WU, Qingyun JIANG, Fengying GUO, Yuyun ZHANG, Hao YU, Ying WANG, Kang SUN, Chengxu ZANG, Chenggang QIN, Xiaobo ZHOU, Xiaojuan ZHANG, Yijin WANG, Xiaoer XIA, Yunfei LI, Jian GE
  • Publication number: 20220024941
    Abstract: Provided are a preparation method for amide compounds and use thereof in medical field. Specifically, provided are small molecule amide compounds. Such compounds are inhibitors of enhancer homolog 2 (EZH2) of Zeste gene, and can be used for preventing and/or treating related diseases mediated by EZH2, including tumors, myeloproliferative diseases or autoimmune diseases.
    Type: Application
    Filed: March 24, 2020
    Publication date: January 27, 2022
    Inventors: Xin XU, Jia CHEN, Zhen ZHANG, Liming ZHANG, Qimei WU, Qingyun JIANG, Fengying GUO, Yuyun ZHANG, Hao YU, Xiaojuan ZHANG, Kang SUN, Xiaobo ZHOU, Chengxu ZANG, Yijin WANG, Xiaoer XIA, Yunfei LI, Jian GE
  • Publication number: 20210309702
    Abstract: The invention includes systems, methods, and compositions for designing secreted fusogenic ectosome vesicles, or gectosomes, that selectively encapsulate specific target proteins, nucleic acids and/or other small molecules in a predetermined manner. These engineered gectosomes can be used to deliver desired cargos to receipt cells in vitro, ex vivo, or in vivo and may further reprogram target cellular phenotypes in a dose-dependent manner, as well as perform genome editing functions, among others.
    Type: Application
    Filed: February 1, 2021
    Publication date: October 7, 2021
    Inventors: Xuedong Liu, Xiaojuan Zhang, Zeyu Liu, Quanbin Xu
  • Patent number: 10917864
    Abstract: The invention relates to the technical field of communications, and more particularly, to a method and device for realizing synchronization. The method comprises: performing, by a base station, and according to an SRS signal transmitted by a terminal, filtering to obtain a RRU channel having the maximum receiving power in a current operation; upon determining that the RRU channel having the maximum receiving power in the current operation is different from a RRU channel used in the currently performed demodulation, refraining from performing immediate switching; and permitting switching of the RRU channel only when the receiving power of the RRU channel is determined to match the maximum threshold of a preset series of thresholds, and transmitting a TA command word to the terminal while switching the RRU channel to complete synchronization with the terminal. The invention prevents a terminal from frequently switching between RRU channels on a subframe basis.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: February 9, 2021
    Assignee: DATANG MOBILE COMMMUNICATIONS EQUIPMENT CO., LTD.
    Inventors: Xiaojuan Zhang, Gang Wu, Xi Wang
  • Patent number: 10793536
    Abstract: The present application provides a vortioxetine pamoic acid salt, which includes a crystal form, a solvate or an amorphous substance of the vortioxetine pamoic acid salt. The present application provides a preparation method and use of the vortioxetine pamoic acid salt and the crystal form thereof. The vortioxetine pamoic acid salt prepared in the present application prolongs the residence time of the vortioxetine in vivo, achieving a slow release of the vortioxetine in vivo, and is suitable for preparing a long-acting dosage form.
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: October 6, 2020
    Assignee: SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD
    Inventors: Yunfei Li, Xiaoer Xia, Xin Xu, Zhen Zhang, Lei Liu, Xiaojuan Zhang, Liming Zhang, Dongsheng Li, Yijin Wang, Jian Ge
  • Patent number: 10638303
    Abstract: Embodiments of this application provide a near-field wireless communication service processing method performed at a first computing device associated with a social networking application. While running a social networking application, the first computing device detects a near-field wireless communication signal broadcasted by a second computing device associated with a service provider account registered with the social networking application.
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: April 28, 2020
    Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED
    Inventors: Kai Ma, Maohua Chen, Mo Zhao, Zhenxi Qiu, Xiaoming Wu, Nan Cheng, Xiaohui Zheng, Junxiong Chen, Jinheng Xie, Zhe Cheng, Le Yu, Shuhui Mei, Chi Zhang, Huiqin Yang, Yao Qin, Shunfu Ye, Tao Zhang, Wenrong Tang, Yangbin Huang, Ming He, Chaoxiong Diao, Pengbo Zhang, Guanqiao Su, Hongmin Zheng, Xiaojuan Zhang, Zhejin Huang, Xiaoyang Qian, Zhongming Guo, Xiaoyi Fang, Yang Zuo, Yan Dai
  • Patent number: 10608861
    Abstract: The present invention discloses a method and system for processing frequency offset, the method includes: obtaining a current frequency offset state; determining whether the current frequency offset state is consistent with a historical effective frequency offset state; wherein the historical effective frequency offset state is a frequency offset state corresponding to a correct decoding result; if it is determined yes, performing a pre-compensation to a fine frequency offset estimation according to the historical effective frequency offset state. The present application solves the problem that inaccurate frequency offset estimation makes it unable to perform frequency offset compensate.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: March 31, 2020
    Assignee: DATANG MOBILE COMMUNICATIONS EQUIPMENT CO., LTD.
    Inventors: Yuetan Chen, Xiaojuan Zhang
  • Publication number: 20190342745
    Abstract: Embodiments of this application provide a near-field wireless communication service processing method performed at a first computing device associated with a social networking application. While running a social networking application, the first computing device detects a near-field wireless communication signal broadcasted by a second computing device associated with a service provider account registered with the social networking application.
    Type: Application
    Filed: July 18, 2019
    Publication date: November 7, 2019
    Inventors: Kai MA, Maohua CHEN, Mo ZHAO, Zhenxi QIU, Xiaoming WU, Nan CHENG, Xiaohui ZHENG, Junxiong CHEN, Jinheng XIE, Zhe CHENG, Le YU, Shuhui MEI, Chi ZHANG, Huiqin YANG, Yao QIN, Shunfu YE, Tao ZHANG, Wenrong TANG, Yangbin HUANG, Ming HE, Chaoxiong DIAO, Pengbo ZHANG, Guanqiao SU, Hongmin ZHENG, Xiaojuan ZHANG, Zhejin HUANG, Xiaoyang QIAN, Zhongming GUO, Xiaoyi FANG, Yang ZUO, Yan DAI
  • Patent number: 10412573
    Abstract: Embodiments of this application provide a near-field wireless communication service processing method performed at a first computing device. While running a social networking application, the first computing device listens to a near-field wireless communication signal broadcasted by a second computing device. After detecting the near-field wireless communication signal broadcasted by the second computing device, first computing device processes the near-field wireless communication signal to obtain identification information associated with the second computing device. The first computing device sends the identification information associated with the second computing device to a remote server supporting the social networking application and obtains a preset service page corresponding to the identification information associated with the second computing device from the server, and displays the preset service page within the social networking application on the first computing device.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: September 10, 2019
    Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED
    Inventors: Kai Ma, Maohua Chen, Mo Zhao, Zhenxi Qiu, Xiaoming Wu, Nan Cheng, Xiaohui Zheng, Junxiong Chen, Jinheng Xie, Zhe Cheng, Le Yu, Shuhui Mei, Chi Zhang, Huiqin Yang, Yao Qin, Shunfu Ye, Tao Zhang, Wenrong Tang, Yangbin Huang, Ming He, Chaoxiong Diao, Pengbo Zhang, Guanqiao Su, Hongmin Zheng, Xiaojuan Zhang, Zhejin Huang, Xiaoyang Qian, Zhongming Guo, Xiaoyi Fang, Yang Zuo, Yan Dai
  • Publication number: 20190268196
    Abstract: The present invention discloses a method and system for processing frequency offset, the method includes: obtaining a current frequency offset state; determining whether the current frequency offset state is consistent with a historical effective frequency offset state; wherein the historical effective frequency offset state is a frequency offset state corresponding to a correct decoding result; if it is determined yes, performing a pre-compensation to a fine frequency offset estimation according to the historical effective frequency offset state. The present application solves the problem that inaccurate frequency offset estimation makes it unable to perform frequency offset compensate.
    Type: Application
    Filed: September 27, 2016
    Publication date: August 29, 2019
    Applicant: DATANG MOBILE COMMUNICATIONS EQUIPMENT CO., LTD
    Inventors: Yuetan CHEN, Xiaojuan ZHANG
  • Publication number: 20190169147
    Abstract: The present application provides a vortioxetine pamoic acid salt, which includes a crystal form, a solvate or an amorphous substance of the vortioxetine pamoic acid salt. The present application provides a preparation method and use of the vortioxetine pamoic acid salt and the crystal form thereof. The vortioxetine pamoic acid salt prepared in the present application prolongs the residence time of the vortioxetine in vivo, achieving a slow release of the vortioxetine in vivo, and is suitable for preparing a long-acting dosage form.
    Type: Application
    Filed: March 28, 2017
    Publication date: June 6, 2019
    Inventors: Yunfei LI, Xiaoer XIA, Xin XU, Zhen ZHANG, Lei LIU, Xiaojuan ZHANG, Liming ZHANG, Dongsheng LI, Yijin WANG, Jian GE
  • Patent number: D897752
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: October 6, 2020
    Assignee: GUANGDONG SHUNDE JIESHI ELECTRIC APPLIANCE CO., LTD.
    Inventor: Xiaojuan Zhang
  • Patent number: D956470
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: July 5, 2022
    Inventor: Xiaojuan Zhang
  • Patent number: D961101
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: August 16, 2022
    Assignee: JIFENG TECHNOLOGY CO., LIMITED
    Inventors: Min Li, Xiaojuan Zhang, Shenghui Zhang
  • Patent number: D1020289
    Type: Grant
    Filed: October 14, 2021
    Date of Patent: April 2, 2024
    Assignee: China Jiangsu International Economic and Technical Cooperation Group, Ltd limited company (Ltd.)
    Inventor: Xiaojuan Zhang